Georgiamune and Menarini Group enter exclusive global license and collaboration agreement for a first-in-class oral immuno-oncology agent. Read today’s press release here: stemline.com/news-and-media/ hashtag#MenariniStemline

Our team had a wonderful few days at JADPRO Live 2026 in Minneapolis, connecting with the advanced practitioner community. We’re returning inspired and motivated as we continue advancing our mission to transform patient care. Thank you to everyone who stopped by! #JADPRO #JADPROLive #MenariniStemline

The Menarini Stemline team is looking forward to the ESMO Congress 2026 in Madrid. We’re excited to be a part of the global oncology discussions that are shaping the future of cancer care. If you’re attending, we’d love to connect. See you in Madrid! #ESMO26 #ESMO #MenariniStemline

Breast cancer can affect anyone. This Men's Breast Cancer Awareness Week, we're focused on a group that is too often left out of the conversation. Because male breast cancer accounts for less than 1% of all breast cancer diagnoses, early signs can be overlooked or dismissed, sometimes leading to a later diagnosis. Awareness helps encourage men to know the signs, speak up, and seek care early. #BreastCancerAwarenessMonth #MensBreastCancerAwareness #BreastCancer #Oncology #MenariniStemline

Members of the Menarini Stemline team were thrilled to attend Lymphoma, Leukemia & Myeloma Congress in NYC. From deep dives into emerging clinical research to connecting with fellow leaders across leukemia, lymphoma, and myeloma, collaborative moments like these reinforce our commitment to advancing hematology research and addressing unmet needs for patients. #Oncology #MenariniStemline

The Menarini Stemline team was pleased to join the hematology and oncology community at the DGHO Annual Meeting in Vienna. It was a valuable few days of scientific exchange and connection with colleagues advancing care for patients with blood cancers and other malignancies across Europe and beyond. #DGHO2026 #MenariniStemline

On #MetastaticBreastCancerAwarenessDay, we're reflecting on our ongoing commitment to the mBC community. Over the past year, we asked our colleagues one question: "What are your three wishes for the mBC community?" Their answers are a reminder that patients are at the heart of everything we do, today and every day. #BreastCancerAwarenessMonth #BreastCancer #mBCAwareness #Oncology #MenariniStemline

The Menarini Stemline team is heading to Minneapolis for JADPRO Live 2026! We’re looking forward to connecting with the advanced practitioner community and sharing our commitment to evolving cancer care. If you’re onsite at #JADPROLive, come find us at our booth. #JADPRO #MenariniStemline

No two breast cancers are exactly alike. What looks like one disease is actually several, and the differences matter, because they shape how each person is treated. Knowing the subtype is a crucial part of getting appropriate care that is tailored to an individual diagnosis. #BreastCancerAwarenessMonth #BreastCancer #mBCAwareness #Oncology #MenariniStemlin

What an inspiring start to Breast Cancer Awareness Month! Our team recently connected with patient advocates and community leaders at the Living Beyond Breast Cancer (LBBC) Fall Summit and the Sisters Network Black Breast Cancer Summit. We’re grateful for the conversations, the connections, and a shared commitment to supporting everyone affected by breast cancer. #BreastCancerAwarenessMonth #BreastCancer #Oncology #MenariniStemline

October marks the beginning of Breast Cancer Awareness Month. For our team at Menarini Stemline, this month is a reminder of why we work relentlessly to advance research and bring new options to the individuals and families impacted by breast cancer, including those facing metastatic disease. Throughout October, we’ll be sharing information and standing alongside the breast cancer community. #BreastCancerAwarenessMonth #BreastCancer #mBCAwareness #Oncology #MenariniStemline

While myelofibrosis (MF) is a rare and complex blood cancer, scientific innovation is continuously driving new hope for MF patients and those who care for them. Traditional approaches have focused on managing symptoms, but the future looks toward advanced combination therapies designed to address the deeper biological causes of the disease and improve long-term well-being. #BloodCancerAwarenessMonth #Oncology #MenariniStemline

Today marks World Cancer Research Day, a time to recognize the discoveries, collaborations and scientific advancements that continue to move cancer research forward. We are grateful to the researchers, healthcare professionals, patients, and advocates whose dedication fuels progress and creates hope for the future. #WorldCancerResearchDay #CancerResearch #Oncology #MenariniStemline

Did you know that Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is most commonly diagnosed in adults between the ages of 60 and 70? While BPDCN can affect both men and women, approximately 75% of cases occur in men. During Blood Cancer Awareness Month, we're highlighting the importance of greater understanding and recognition of rare blood cancers like BPDCN. Learn more about BPDCN at bpdcninfo.com. #BloodCancerAwarenessMonth #Oncology #MenariniStemline

Our team was pleased to join the international pathology community at the European Society of Pathology (ESP) Congress in Stockholm. It was a valuable few days of scientific exchange and connection with colleagues dedicated to advancing biomarker testing and improving care for patients worldwide. #MenariniStemline

Multiple myeloma accounts for 10–15% of all blood cancers, with ~188,000 cases diagnosed globally each year. Over the past 20 years, survival outcomes for multiple myeloma have improved substantially, thanks to incredible medical innovations. While it remains a complex blood cancer, the oncology community, including Menarini Stemline, is fighting back by advancing research and supporting patients with this disease. #BloodCancerAwarenessMonth #Oncology #MenariniStemline

Thank you to everyone who visited the Menarini Stemline booths at #SOHO2026! It was energizing to connect with the global hematology community and discuss the latest advancements in blood cancer research and patient care. #MenariniStemline

This Blood Cancer Awareness Month, we're helping raise awareness of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), an aggressive orphan blood cancer. Although BPDCN can affect multiple parts of the body, it most commonly involves the skin, bone marrow, and blood. Learn more about BPDCN at bpdcninfo.com. #BloodCancerAwarenessMonth #Oncology #MenariniStemline

Happy Labor Day from Menarini Stemline. Today we recognize the dedication, talent, and hard work of our colleagues, as well as workers across our communities whose contributions make a difference every day. Thank you for all that you do! #LaborDay #MenariniStemline